Healios K.K.
HLOSF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -99.4% | -42.1% | 111.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -494.7% | -209.1% | 23.7% | -66.7% |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | -4,021.1% | -3,931.8% | -2,007.9% | -4,833.3% |
| Other Income/Exp. Net | $0 | -$1 | -$2 | $1 |
| Pre-Tax Income | $0 | -$2 | -$3 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$2 | -$3 | $0 |
| % Margin | 2,963.2% | -9,763.6% | -6,742.1% | 1,422.2% |
| EPS | 0.033 | -20.57 | -26.72 | 2.84 |
| % Growth | 100.2% | 23% | -1,040.8% | – |
| EPS Diluted | 0.033 | -20.57 | -26.72 | 2.84 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $0 | $1 | $2 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$1 | -$1 | -$1 |
| % Margin | 3,352.6% | -3,468.2% | -1,778.9% | -4,400% |